Document is current

Article History

Received: 14 June 2024

Accepted: 12 March 2025

First Online: 7 May 2025

Declarations

:

: The study and amendments were reviewed by an independent ethics committee or institutional review board at each study site: Ethics Committee of Peking University People’s Hospital (#2020PHB401-01); Ethics Committee on Biomedical Research, West China Hospital of Sichuan University (#2021-EC-122); Medical Ethics Committee of Qilu Hospital, Shandong University (#(Ke)-EC-2020044); Medical Ethics Committee of Henan Provincial Cancer Hospital (#2020-289-001); Medical Ethics Committee of Tianjin Cancer Hospital (#E20210167); Human Research Ethics Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine (#2021-EC-2023); Ethics Committee of Shengjing Hospital, China Medical University (#2021PS008T); Ethics Committee of Beijing Hospital (#2021BJYYEC-093-02); Ethics Committee of Anhui Provincial Cancer Hospital (#EC-2021-10); Ethics Committee of Henan Provincial People’s Hospital (#2021-105-02); Ethics Committee of the Affiliated Hospital of Nantong University (#2021-K086-01); Ethics Committee of Tianjin Medical University General Hospital (#IRB2021-058-01); Ethics Committee of Qingdao Municipal Hospital (#2021-EC-017). The study and amendments were conducted in accordance with the principles of the Declaration of Helsinki and consistent with Good Clinical Practice guidelines and applicable regulatory requirements. All patients provided written informed consent prior to study participation.

: Not applicable.

: Yanhui Li, Jianmin Zhuo, Xi Chen, and Canchan Cui are employees of Johnson & Johnson. Yishen Yang is an employee of IQVIA, which was contracted by Johnson & Johnson for the presented analyses. Jin Lu has served as a consultant and participated in the speakers bureau for Johnson & Johnson. The remaining authors have no competing interests to declare.